Biotechs are seeking new incentives to lure and retain researchers.

Streamlining after Pharmacia merger will cut at least 500 jobs in United States and Europe.

Purdue competition rewards best life science business plans in tough times.

In a week of landmark events for genomics, a survey of the landscape.

Security specialist proposes international regulation of potentially dangerous research.

Microbiologists told their talks with the agency about data-sharing will be secret

Genaissance deal illustrates stark outlook for basic researchers

Oregon and California rivals vie for biocontainment lab grant, one facing strong local opposition.

Court confirms fudged science behind Roche PCR patent, but fight for enzyme rights is not over.

FBI to start fingerprinting scientists who want to work with dangerous agents.

US government agencies still using discredited polygraphy in security checks.

Spat over rights to one technique settled, but many more remain.